OR WAIT null SECS
September 15, 2025
Video
Arora discusses the results of Bristol Myers Squibb’s observational study and the implications it has for the study of obstructive HCM and cardiology at large.
September 03, 2025
Article
A recap 8 clinical trials in cardiovascular care to know from the European Society of Cardiology Congress 2025.
August 30, 2025
Aficamten shows significant benefits over metoprolol in treating symptomatic obstructive HCM, potentially changing first-line therapy approaches.
Aficamten displayed superior improvements in peak oxygen uptake and hemodynamics compared to the most commonly used beta-blocker for symptomatically obstructive HCM.
July 11, 2025
Capricor Therapeutics intends to resubmit a BLA for the potential first-in-class treatment with topline data from the ongoing HOPE-3 trial in Q3 2025.
June 08, 2025
Lopez reviews findings from an analysis of ARISE-HF highlighting racial and ethnic differences in baseline characteristics and diabetic cardiomyopathy disease progression.
June 03, 2025
Discover key advancements and setbacks in cardiovascular medicine from May 2025, shaping the future of cardiometabolic care and treatment options.
May 19, 2025
Latest analysis of the HELIOS-B trial finds vutrisiran significantly lowers mortality and cardiovascular events in patients with ATTR-CM.
May 16, 2025
Podcast
Hosts explore the latest advancements in amyloidosis treatment, with expert insights on emerging therapies and patient care strategies.
April 22, 2025
The model could allow cardiologists to inform and prepare patients before symptoms of hypertrophic cardiomyopathy make themselves known.
